Literature DB >> 31521844

Predictors of 30-day rehospitalization in a sample of hospitalized patients with Bipolar I disorder.

Melanie L Bozzay1, Brandon A Gaudiano2, Sarah Arias2, Gary Epstein-Lubow3, Ivan W Miller2, Lauren M Weinstock2.   

Abstract

The transition from psychiatric hospitalization to home is marked by high clinical vulnerability, characterized by risk of symptom rebound, exposure to preexisting stressors, and challenges with outpatient treatment linkage. Rates of rehospitalization during this post-discharge period, particularly for those with bipolar disorder, are reported to be high. This study evaluated demographic and clinical predictors of early rehospitalization (within 30 days) in a sample of hospitalized adults with Bipolar I disorder (BD-I). A chart review was conducted for 215 patients with BD-I admitted to an academically-affiliated psychiatric hospital within one calendar year. A computer algorithm was used to extract relevant demographic, clinical, and treatment information. Univariate and multivariate logistic regression models were used to examine predictors of early rehospitalization. Overall, 12% of participants were readmitted within 30 days of discharge. Controlling for other clinical and demographic variables, patient functioning and pre-admission psychiatric polypharmacy, but not comorbid psychiatric diagnoses, predicted early readmission in patients with BD-I. Findings highlight the relative importance of considering low psychosocial functioning, and medication regimens containing multiple psychiatric medications, during hospitalizations. These features may indicate a subset of patients with BD-I who require more comprehensive discharge planning and support to transition to the community following a psychiatric hospitalization. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar Disorder; Early Rehospitalization; Polypharmacy

Year:  2019        PMID: 31521844      PMCID: PMC6924623          DOI: 10.1016/j.psychres.2019.112559

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

1.  Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.

Authors:  Vicki C Fung; Lindsay N Overhage; Louisa G Sylvia; Noreen A Reilly-Harrington; Masoud Kamali; Keming Gao; Richard C Shelton; Terence A Ketter; William V Bobo; Michael E Thase; Joseph R Calabrese; Mauricio Tohen; Thilo Deckersbach; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2019-07-02       Impact factor: 4.839

2.  Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

Authors:  Joseph F Goldberg; John O Brooks; Keiko Kurita; Jennifer C Hoblyn; S Nassir Ghaemi; Roy H Perlis; David J Miklowitz; Terence A Ketter; Gary S Sachs; Michael E Thase
Journal:  J Clin Psychiatry       Date:  2009-02-10       Impact factor: 4.384

Review 3.  Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence.

Authors:  Lucy J Robinson; I Nicol Ferrier
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

Review 4.  Disability and its treatment in bipolar disorder patients.

Authors:  Nancy Huxley; Ross J Baldessarini
Journal:  Bipolar Disord       Date:  2007 Feb-Mar       Impact factor: 6.744

5.  National trends in psychotropic medication polypharmacy in office-based psychiatry.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Arch Gen Psychiatry       Date:  2010-01

Review 6.  Goals of inpatient treatment for psychiatric disorders.

Authors:  Steven S Sharfstein
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

7.  Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Gary Epstein-Lubow; Katherine Tezanos; Cintly E Celis-Dehoyos; Ivan W Miller
Journal:  Psychiatry Res       Date:  2014-02-01       Impact factor: 3.222

8.  The Burden of Repeated Mood Episodes in Bipolar I Disorder: Results From the National Epidemiological Survey on Alcohol and Related Conditions.

Authors:  Amy T Peters; Amy E West; Lori Eisner; Jihyun Baek; Thilo Deckersbach
Journal:  J Nerv Ment Dis       Date:  2016-02       Impact factor: 2.254

Review 9.  Costs of bipolar disorder.

Authors:  Leah Kleinman; Ana Lowin; Emuella Flood; Gian Gandhi; Eric Edgell; Dennis Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Relapse and impairment in bipolar disorder.

Authors:  M J Gitlin; J Swendsen; T L Heller; C Hammen
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.